EMMI, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.113
EU - Europa 10.778
AS - Asia 3.630
OC - Oceania 133
SA - Sud America 112
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 2
Totale 29.824
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.064
RU - Federazione Russa 4.385
PL - Polonia 1.894
IT - Italia 1.506
HK - Hong Kong 1.338
IE - Irlanda 1.201
SG - Singapore 893
SE - Svezia 775
CN - Cina 619
IN - India 237
JO - Giordania 210
DE - Germania 202
CH - Svizzera 183
FI - Finlandia 159
GB - Regno Unito 135
AU - Australia 131
ID - Indonesia 123
BR - Brasile 91
VN - Vietnam 70
ES - Italia 63
NL - Olanda 63
AT - Austria 58
CI - Costa d'Avorio 39
TR - Turchia 38
FR - Francia 37
UA - Ucraina 37
CA - Canada 36
BE - Belgio 25
SA - Arabia Saudita 14
DK - Danimarca 13
KR - Corea 12
IL - Israele 11
CZ - Repubblica Ceca 9
GR - Grecia 9
IR - Iran 9
PE - Perù 9
MA - Marocco 6
AZ - Azerbaigian 5
KG - Kirghizistan 5
MX - Messico 5
AM - Armenia 4
GE - Georgia 4
IQ - Iraq 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
LT - Lituania 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AR - Argentina 3
EG - Egitto 3
JP - Giappone 3
PS - Palestinian Territory 3
RO - Romania 3
SC - Seychelles 3
TW - Taiwan 3
BO - Bolivia 2
CO - Colombia 2
CR - Costa Rica 2
EC - Ecuador 2
EU - Europa 2
HR - Croazia 2
KH - Cambogia 2
LV - Lettonia 2
MU - Mauritius 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PY - Paraguay 2
UZ - Uzbekistan 2
BD - Bangladesh 1
BG - Bulgaria 1
EE - Estonia 1
HU - Ungheria 1
JM - Giamaica 1
LK - Sri Lanka 1
MK - Macedonia 1
NI - Nicaragua 1
NP - Nepal 1
PK - Pakistan 1
TH - Thailandia 1
TM - Turkmenistan 1
TN - Tunisia 1
VE - Venezuela 1
Totale 29.824
Salva come PNG Salva come JPEG
Città #
Santa Clara 5.005
Warsaw 1.890
Fairfield 1.509
Dublin 1.199
Hong Kong 1.105
Chandler 850
Ashburn 815
Singapore 696
Woodbridge 647
Seattle 582
Houston 529
Cambridge 509
Wilmington 420
Lawrence 403
Altamura 356
Florence 329
Moscow 308
Princeton 280
Mumbai 217
Ann Arbor 213
Boston 212
Beijing 182
Bern 175
Buffalo 153
Shanghai 134
Melbourne 130
Jakarta 123
New York 116
San Diego 116
Helsinki 98
Medford 98
Boardman 90
Los Angeles 72
Kent 63
Rome 58
Vienna 57
Dong Ket 56
Falls Church 53
Norwalk 50
Milan 47
Barcelona 44
Munich 40
Abidjan 39
Hillsboro 39
London 36
Redwood City 29
Toronto 29
Guangzhou 27
Yubileyny 27
Brussels 25
Castelliri 23
Andover 20
Lappeenranta 19
Genoa 18
Washington 18
Bari 17
West Jordan 16
Jacksonville 15
Phoenix 15
Bologna 13
Falkenstein 12
Paris 12
Copenhagen 11
Kilburn 11
Pune 11
Seoul 11
Dearborn 10
Nuremberg 10
Palermo 10
Arezzo 9
Napoli 9
Redmond 9
Amman 8
Campi Bisenzio 8
Lima 8
Nanjing 8
Padova 8
Siena 8
Frankfurt am Main 7
Jinan 7
Laurel 7
São Paulo 7
Verona 7
Athens 6
Naples 6
New Bedfont 6
Newark 6
Old Bridge 6
Pamplona 6
Parma 6
Perugia 6
Rabat 6
Rolla 6
Tel Aviv 6
Turin 6
Wuhan 6
Amsterdam 5
Baku 5
Bishkek 5
Brno 5
Totale 20.760
Salva come PNG Salva come JPEG
Nome #
Behçet's syndrome patients exhibit specific microbiome signature. 298
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 285
An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions. 278
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 262
SIRT1 activity is decreased in lesional psoriatic skin 246
Central vein sign differentiates MS from CNS inflammatory vasculopathies. 243
Repeated low-dose courses of rituximab in SLE-associated antiphospholipid syndrome: Data from a tertiary dedicated centre 235
Digital ulcers secondary to Sneddon's syndrome successfully treated with Bosentan: not only useful in Systemic Sclerosis 220
Sirt1 Protects against Oxidative Stress-Induced Apoptosis in Fibroblasts from Psoriatic Patients: A New Insight into the Pathogenetic Mechanisms of Psoriasis 216
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 200
A biochemical approach to detect oxidative stress in infertile women undergoing assisted reproductive technology procedures 195
First report of FIP1L1-PDGFR alpha-positive eosinophilic granulomatosis with polyangiitis 182
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 178
ANCA-associated vasculitis in childhood: Recent advances 173
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 171
Thrombosis in vasculitis: from pathogenesis to treatment 166
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. 164
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 158
Role of polymorphonucleates in the pathogenesis of systemic juvenile idiopathic arthritis and Still's disease: A proof of concept study 156
Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment 156
Behcet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils 155
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 155
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 148
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 147
Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature 147
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 146
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 146
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 143
Thrombosis in inflammatory bowel diseases: What's the link? 141
Cardiac involvement in Churg Strauss syndrome: an update on cardiological manifestations 141
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 141
Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress 140
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? 136
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 135
The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit 134
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 134
Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report 133
Intravenous immunoglobulin therapy: a snapshot for the internist. 133
Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome 133
Pathogenesis of Behcet Syndrome 131
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 130
Erythrocyte membrane fluidity alterations in sudden sensorineural hearing loss patients: The role of oxidative stress 130
Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets 129
Redox status alterations during the competitive season in élite soccer players: focus on peripheral leukocyte-derived ROS 129
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 129
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet’s Disease 129
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: A multicenter study from the AIDA Network PFAPA syndrome registry 128
Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: An uncommon adverse effect? 127
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet's phenotype: A multicentre study 126
The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. 126
Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome 126
Lobular panniculitis with small vessel vasculitis associated with ulcerative colitis. 124
Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects 123
Brief Report: Rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schönlein purpura) 123
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 121
Significance of PR3-ANCA Positivity in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) 121
The "multifaceted" onset of vasculitis neuropathy 120
Cytomegalovirus retinitis following intravitreal dexamethasone implant in a patient with central retinal vein occlusion 119
The Presence of Uveitis Is Associated With a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 119
A unique circulating miRNA profile highlights thrombo-inflammation in Behçet's syndrome 119
Sharing data of clinical trials 118
Pharmacological prevention of venous thromboembolism in orthopaedic surgery 117
Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experience 117
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 117
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 117
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 117
OP0148 MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS 117
A case of lichenoid drug eruption associated with subcutaneous immunoglobulin therapy. 116
Infliximab and Cogan's syndrome 116
Rapid desensitization to anakinra-related delayed reaction: Need for a standardized protocol 116
Prognostic Value of Degree and Types of Anaemia on Clinical Outcomes for Hospitalised Older Patients 115
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 115
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis 114
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 113
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 113
Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome 113
Pulmonary hemorrhage: not only vasculitis. 112
Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study 111
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 111
CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis 111
MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases. 111
The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review 110
I farmaci biologici 110
New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy 109
Reply: anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series 108
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 108
Clinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 Patients 108
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 108
THU0540 Efficacy and safety of adalimumab in behÇet's disease related uveitis: a multicenter retrospective observational study 108
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 108
Anakinra for resistant Behçet uveitis: why not? 107
Favorable pregnancy outcome in a patient with systemic lupus erythematosus treated with belimumab: A confirmation report 107
Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis 107
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 107
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 107
Microparticles: Bridging the gap between autoimmunity and thrombosis 106
Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies. 106
Rituximab for chronic periaortitis without evidence of IgG4-related disease: A long-term follow-up study of 20 patients 106
Predictors of Sustained Clinical Response in Patients With Behçet's Disease-Related Uveitis Treated With Infliximab and Adalimumab 106
Long-term Retention Rates of Adalimumab and Infliximab in Non-Infectious Intermediate, Posterior, and Panuveitis 105
Totale 13.947
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.039
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.012 0 0 0 0 0 0 0 0 326 233 237 216
2020/20212.768 155 257 102 463 240 211 223 168 307 326 147 169
2021/20221.959 56 75 231 74 50 130 50 215 125 82 281 590
2022/20235.057 450 1.102 267 219 219 871 681 266 496 63 179 244
2023/20242.502 92 172 342 162 162 352 128 481 77 235 154 145
2024/202513.516 598 1.722 896 2.595 4.267 2.016 460 790 172 0 0 0
Totale 30.354